Navigation Links
DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
Date:8/11/2009

WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.((R)) (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan((R)) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090810/DC59366LOGO)

Financial highlights for the second quarter and first half of the year include:

  • Domestic PDT revenues totaled $6.1 million for the second quarter of 2009, representing a $1.2 million, or 24%, improvement as compared to the second quarter of 2008. First half 2009 domestic PDT revenues totaled $12.4 million, representing a $2.3 million, or 22%, improvement year over year.
  • Domestic Kerastick((R)) revenues totaled $5.6 million for the second quarter of 2009, representing a $1.0 million, or 23%, improvement as compared to the second quarter of 2008. First half 2009 domestic Kerastick((R) )revenues totaled $11.3 million, representing a $2.0 million, or 21%, improvement year over year.
  • Domestic BLU-U((R)) revenues totaled $0.5 million for the second quarter of 2009, representing a $0.1 million, or 38%, improvement as compared to the second quarter of 2008. First half 2009 domestic BLU-U((R)) revenues totaled $1.1 million, representing a $0.3 million, or 36%, improvement year over year.
  • Kerastick((R)) gross margins for the second quarter of 2009 reached a record high of 85%.

Management Comments:

"While
'/>"/>

SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, ... contract lifecycle management solution, as well as announced the date of its next ... and ease of contract management tasks as well as enhancements to the customer ...
(Date:8/3/2015)... Pass, OR (PRWEB) , ... August 03, 2015 ... ... Northeast California’s Modoc National Forest, to Ahjumawi Lava Springs, California’s northernmost and among ... of California’s largest untapped ground water aquifers, whose main outflow is at Ahjumawi ...
(Date:8/3/2015)... ... , ... Illinois Health & Science (IHS) has completed the purchase of IBA ... of IBAM NA’s cyclotron sites and research and development facilities. , “We ... well as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and ...
(Date:8/3/2015)... ... , ... Foot and Ankle Specialists of the Mid-Atlantic (FASMA) is ... practice in the Mid-Atlantic region – and the second largest in the United States ... , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew up in Laurel, Maryland. ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, ... exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in ... for the opportunity the AHDI conference provides us to interact with those in ...
Breaking Medicine News(10 mins):Health News:Novatus Unveils Milestone Software Release 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
... , WEDNESDAY, Dec. 8 (HealthDay News) -- A new ... blood to scan the genome of a fetus may offer ... genetic diseases, a new study suggests. Currently, a sample ... amniocentesis or chorionic villus sampling, both of which pose a ...
... HealthDay Reporter , WEDNESDAY, Dec. 8 (HealthDay News) -- Allison Glover ... little more than two months after she gave birth to him ... seven weeks early, on Feb. 23, 2000, but both had relatively ... and living in Stone Mountain, Ga. Garrett seemed the ...
... Patients who have complications after colorectal cancer surgery ... is clearly recommended for their diagnosis, a new study ... In addition, patients with complications were more than ... more than 120 days after diagnosis or two months ...
... Learning to read and write are complex processes, which ... known as dyslexia and dysgraphia. Two new studies, published ... ( http://www.sciencedirect.com/science/journal/00109452 ) provide evidence of this variety, ... account. A group of researchers from the Universities ...
... becoming tastier and more appealing to consumers thanks to new ... forms of fiber, which could be a boon to health, ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine. ... plays key roles in human health. Fiber creates a feeling ...
... -- Kidney failure patients who are married are more likely ... or widowers or have never married, finds a new study. ... with end-stage kidney failure. Previous research has shown that males, ... more likely than others to receive kidney transplants in the ...
Cached Medicine News:Health News:Mother Talks of the Anger, Confusion and Grief of a SIDS Death 2Health News:Mother Talks of the Anger, Confusion and Grief of a SIDS Death 3Health News:Surgery complications linked to chemotherapy delay, U-M study finds 2Health News:Widening our perceptions of reading and writing difficulties 2Health News:Marital Status May Affect Kidney Transplant Decision 2
(Date:8/3/2015)... N.J. , Aug. 3, 2015  Celsion ... the Company will host a conference call to ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. EDT on Monday, August 10, 2015. To ...
(Date:8/3/2015)... -- Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: IMNP ), ... will present live at VirtualInvestorConferences.com on August 6, 2015. ... EDT LINK:    http://tinyurl.com/aug6-pre-imnp This ... are invited to ask the company questions in real-time ... the association,s "virtual trade booth." If attendees are not ...
(Date:8/3/2015)... BOULDER, Colo., Aug. 3, 2015  Encision Inc. (PK:ECIA), ... prevents dangerous stray electrosurgical burns in minimally invasive surgery, ... quarter that ended June 30, 2015. The ... a quarterly net loss of $213 thousand, or $(0.02) ... $2.476 million for a net loss of $202 thousand, ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5
Rad-5v signal extraction pulse oximeter™...
... The WristOx® 3100 is a ... to be worn comfortably on ... monitoring daily activities and for ... of the WristOx is intended ...
... The PulseOx 5500TM is the ... blood oxygen saturation and heart rate ... The PulseOx 5500TM uses SPO Medicals ... device which is more usable for ...
All-in-One Fingertip Oximeter...
Medicine Products: